Corporate Workshops
The Corporate Workshops are independent from the ISLH educational content. Please review the available workshops below. Details are subject to change.
Michelle Grant, DO
Director of Hematology and Coagulation
Geisinger Medical Laboratories
Stephen Postma
Enterprise Architect and Innovation Leader
Sysmex America, Inc.
This session will discuss how CBC data can be used to optimize lab diagnostics and foster value-based care. The speakers will describe how they plan to use core outcome data sets with CBC results to measure patient outcomes. Through the use of machine learning and data analytics predictive models will be built to improve patient care.
Objectives:
This workshop will be available to watch on-demand starting May 5.
As part of the innate immune response system, Monocytes are central in homeostasis and disease across infectious and inflammatory presentations. Monocyte Distribution Width (MDW) is a quantitative measure of variability in monocyte morphology. MDW has recently received regulatory clearance for aiding in the diagnosis of adult sepsis in Emergency Department and is available today with CBC-Diff results early in patients’ triage. Join Beckman Coulter’s ISLH 2021 workshop, where Dr. Czader, (United States) and Dr. Morales, (Spain) will discuss the role of monocyte morphology in clinical decision-making and present emerging evidence based on multicentric European clinical trials. Comparing MDW performance with procalcitonin and C-reactive protein, they will discuss how all these biomarkers can be implemented in real practice to improve sepsis detection and patient outcomes.
Presenters:
Dr. Magdalena Czader - Roles of Monocytes in Innate Immune Response across infectious and inflammatory presentations
Dr. Cristian Morales-Indiano - Monocyte Distribution Width: Clinical Evidence from Multicenter Studies
This workshop will be available to watch on-demand starting May 5.
Myelodysplastic syndromes (MDS) are clonal myeloid neoplasms characterized by morphologic dysplasia, cytopenia and having propensity for acute leukemic transformation. However, dysplasia is determined by morphology and may be present in reactive conditions. In this presentation, several CBC parameters demonstrating significant differences between MDS and other cytopenia patients will be discussed. The application of these parameters and their impact on diagnosis of MDS and patient management will be reviewed.
Presenters:
Dr. Sang Mee Hwang, Clinical associate professor, Seoul National University Bundang Hospital